2m 2m 2m 2m 2m 2m 2m
SCYNEXIS (SCYX)
NASDAQ
$5.15+$0.04 (+0.88%)
Price as of Aug 21, 2026 7:30 PM EDT- $50.7MMarket Cap
- -21.87%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
SCYNEXIS (SCYX)
$5.15+$0.04 (+0.88%)
SCYX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.10 | ||
Change | -$0.12 (-2.30%) | ||
Open | $5.29 | ||
High | $5.41 | ||
Low | $5.05 | ||
Previous Close | $5.22 | ||
Volume | 35,178 | ||
30-Day Average Volume | 234,401 | ||
1-Week Change | -1.54% | ||
1-Month Change | 25.93% | ||
1-Year Change | -21.87% | ||
3-Year Change | -79.37% | ||
5-Year Change | -89.14% | ||
Fundamentals | |||
Shares Outstanding | 9.9M | ||
Total Assets | $75.0M | ||
Market Cap | $50.7M | ||
Enterprise Value | $40.3M | ||
Period: QTR TTM FY | |||
Revenue | $235,000.00 | ||
Net Income | $7.4M | ||
Free Cash Flow | -$14.9M | ||
EBIT | $7.4M | ||
EBITDA | $7.4M | ||
Net Working Capital | $50.4M | ||
EPS | $0.63 | ||
Enterprise Value/EBITDA | 5 | ||
Enterprise Value/Revenue | 171 | ||
P/B | 1 | ||
P/E | 8 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 8 | ||
Last Split Date | 06/01/2026 | ||
Earnings & Revenue